Document:

Exhibit

Exhibit 10.9

Summary of Pixelworks Non-Employee Director Compensation
	
			
	Applicable Period
	January 1, 2019 - December 31, 2019
	January 1, 2020 - Current

	General Board Service - Cash
	Annual Retainer: $40,000
	Annual Retainer: $40,000

	General Board Service - Equity
	Initial grant upon election or appointment: $74,000 fair value in stock options (based on Black-Scholes valuation assumptions consistent with the Company’s financial reporting obligations and 30-day average stock price) with a six year term vesting 25% on the first anniversary of the grant date, and ratably on a monthly basis thereafter for the next three years, subject to acceleration on change of control

Annual grant at annual meeting of shareholders:  $74,000 fair value in RSUs (based on 30-day average stock price) vesting on first to occur of (1) the day before the next annual meeting of the Company’s shareholders that follows the grant date, or (2) the first anniversary of the grant date, subject to acceleration on change of control
	Initial grant upon election or appointment: $74,000 fair value in stock options (based on Black-Scholes valuation assumptions consistent with the Company’s financial reporting obligations and 30-day average stock price) with a six year term vesting 25% on the first anniversary of the grant date, and ratably on a monthly basis thereafter for the next three years, subject to acceleration on change of control

Annual grant at annual meeting of shareholders:  $74,000 fair value in RSUs (based on 30-day average stock price) vesting on first to occur of (1) the day before the next annual meeting of the Company’s shareholders that follows the grant date, or (2) the first anniversary of the grant date, subject to acceleration on change of control

	Committee Member Service - Additional Annual Fees
	Committee member annual fees:

Audit: $8,000 (paid quarterly)

Comp: $5,000 (paid quarterly)

Corp Gov/Nom: $3,000 (paid quarterly)

	Committee member annual fees:

Audit: $8,000 (paid quarterly)

Comp: $5,000 (paid quarterly)

Corp Gov/Nom: $3,000 (paid quarterly)

	Committee Chair Service - Additional Annual Fees
	Committee Chair fees:

Audit: $19,000 (paid quarterly)

Comp: $10,000 (paid quarterly)

Corp Gov/Nom: $7,500 (paid quarterly)

	Committee Chair fees:

Audit: $19,000 (paid quarterly)

Comp: $10,000 (paid quarterly)

Corp Gov/Nom: $7,500 (paid quarterly)

	Chairman of the Board
	Additional annual retainer: $25,000
	Additional annual retainer: $28,000Exhibit 10.1

 

THE SECURITIES REPRESENTED BY
THIS DOCUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY
NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS SUCH SALE, TRANSFER OR ASSIGNMENT IS COVERED BY AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT, OR SATISFIES THE REQUIREMENTS OF RULE 144 OF THE SECURITIES AND EXCHANGE COMMISSION, OR IS EFFECTED
PURSUANT TO AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER THAT SUCH SALE, TRANSFER OR ASSIGNMENT IS EXEMPT FROM SUCH REGISTRATION.

 

ODYSSEY GROUP
INTERNATIONAL, INC.

 

CONVERTIBLE PROMISSORY
NOTE

 

	$	 	 
	(AMOUNT)	 	(DATE)

 

Odyssey
Group International , Inc., a Nevada corporation (the “Company”), for value received, promises to pay to the order
of (NAME) __________________________ permitted assigns (“Holder”), the principal sum of (WRITTEN
AMOUNT) ___________________  (NUMBER AMOUNT) ($________________) plus
simple interest thereon from the date of this Note until fully-paid at the rate of seven percent (7%) per annum or such lesser
rate of interest as may be required by applicable laws regulating the legal rate of interest.

 

1. 
Maturity. This Note shall mature automatically and the entire outstanding principal amount, together with
all interest accrued under this Note, shall become due and payable on the date that is one (1) year from the date of issuance
(“Maturity Date”), unless this Note, before such date, is converted into shares of capital stock of the Company
pursuant to Section 5 hereof.

 

2. 
Payment of Principal and Interest. Interest payments shall be accrued to the principle on an annual basis.Such
interest payments may, at the discretion of the Board of Directors, also be payable in common restricted stock of the Company,
that is subject the same trickle out agreement as converted stock in this agreement, the conversion price of interest paid shall
be the closing price of Company stock on the anniversary date of the investment.

 

3.  Prepayment
and Trickle out Agreement.

 

(a)     This
Note may be prepaid at any time or from time to time, in whole or in part.

 

4. 
Waiver of Presentment. The Company hereby waives presentment of this Note, protest, dishonor and notice of
dishonor.

 

5. 
Conversion of Note.

 

(a)     Conversion
into Stock. At the option of the Holder, the principal amount of this Note and any accrued interest may be converted into
fully-paid and nonassessable shares of common stock at the Conversion Price (as defined herein). At maturity, the loan and all
interest may be converted to common restricted stock of the Company automatically or the Company shall have right to either pay
off the loan and any interest accrued or convert the loan amount and any interest into shares of common stock. The number of such
shares of common stock that Holder shall be entitled to receive, and shall receive, upon such conversion shall be determined by
dividing the aggregate amount of principal and interest under this Note being so converted by the Conversion Price (as defined
herein). Holder agrees to execute and deliver the form of Notice of Conversion attached hereto. Upon receipt by the Company of
any such Notice of Conversion, the election to convert shall be irrevocable and the date the Notice of Conversion was executed
by the Holder shall be the “Conversion Date”.

 

 

 

 

    	 	1	 

     

    

 

(c)     Conversion
Price. Subject to adjustment as provided below, the “Conversion Price” shall equal one dollar ($1.00) per
share or at a 10% discount to the closing price on the day of conversion but in no instance shall it be below eighty cents ($0.80).

 

(d)     Stock
Certificates. Upon conversion into common stock, the Company shall issue and deliver to Holder, or to Holder’s nominee
or nominees, a certificate or certificates representing the number of shares of common stock to which Holder shall be entitled
as a result of conversion as provided herein.

 

(e)     Adjustments
to Conversion Price for Diluting Issues.

 

(i)      
Special Definitions. For purposes of this Subsection 5(d), the following definitions shall apply:

 

(A) "Original
Issue Date" shall mean the date on which the Note is first issued.

 

(B) 
"Convertible Securities" shall mean any evidences of indebtedness, shares or other securities directly or indirectly
convertible into or exchangeable for Common Stock.

 

(C) 
"Additional Shares of Common Stock" shall mean all shares of Common Stock issued (or, pursuant to Subsection 5(d)(iii)
below, deemed to be issued) by the Company after the Original Issue Date, and other than shares of Common Stock issued or issuable:

 

(1) as
a dividend or distribution on all shares of Common Stock;

 

(2) 
by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock excluded from the definition
of Additional Shares of Common Stock by the foregoing clause (1);

 

(3) 
upon the exercise of options excluded from the definition of "Option" in Subsection 5(d)(i)(A); or

 

(4) upon
conversion of the Notes.

 

 

 

 

    	 	2	 

     

    

 

(f)     "Rights
to Acquire Common Stock" (or "Rights") shall mean all rights issued by the Company to acquire common stock whatever
by exercise of a warrant, option or similar call or conversion of any existing instruments, in either case for consideration fixed,
in amount or by formula, as of the date of issuance.

 

(ii) 
No Adjustment of Conversion Price. No adjustment in the number of shares of Common Stock issuable upon conversion
of the Notes shall be made, by adjustment in the applicable Conversion Price thereof: (a) unless the consideration per share (determined
pursuant to Subsection 5(d)(v)) below for an Additional Share of Common Stock issued or deemed to be issued by the Company is
less than the applicable Conversion Price in effect on the date of, and immediately prior to, the issue of such additional shares,
or (b) if prior to such issuance, the Company receives written notice from the holders of at least a majority of the then outstanding
Notes (determined by principal amount) agreeing that no such adjustment shall be made as the result of the issuance of Additional
Shares of Common Stock.

 

(iii)
Issue of Securities Deemed Issue of Additional Shares of Common Stock. If the Company at any time or from time to time
after the Original Issue Date shall issue any Options or Convertible Securities or other Rights to Acquire Common Stock, then
the maximum number of shares of Common Stock (as set forth in the instrument relating thereto without regard to any provision
contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options, Rights or, in the case
of Convertible Securities, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares
of Common Stock issued as of the time of such issue, provided that Additional Shares of Common Stock shall not be deemed to have
been issued unless the consideration per share (determined pursuant to Subsection 5(d)(v) hereof) of such Additional Shares of
Common Stock would be less than the applicable Conversion Price in effect on the date of and immediately prior to such issue,
or such record date, as the case may be, and provided further that in any such case in which Additional Shares of Common Stock
are deemed to be issued:

 

(A) 
No further adjustment in the Conversion Price shall be made upon the subsequent issue of shares of Common Stock upon the
exercise of such Rights or conversion or exchange of such Convertible Securities;

 

(B) 
Upon the expiration or termination of any unexercised Option or Right, the Conversion Price shall not be readjusted, but
the Additional Shares of Common Stock deemed issued as the result of the original issue of such Option or Right shall not be deemed
issued for the purposes of any subsequent adjustment of the Conversion Price; and

 

 

 

 

    	 	3	 

     

    

 

Notwithstanding
the foregoing, the applicable Conversion Price shall not be reduced if the amount of such reduction would be an amount less than
eighty cents ($0.80), but any such amount shall be carried forward and reduction with respect thereto made at the time of and together
with any subsequent reduction which, together with such amount and any other amount or amounts so carried forward, shall aggregate
eighty cents ($0.80) or more.

 

(v) 
Determination of Consideration. For purposes of this Subsection 5(d), the consideration received by the Company
for the issue of any Additional Shares of Common Stock shall be computed as follows:

 

(A) Cash
and Property: Such consideration shall:

 

(1) 
insofar as it consists of cash, be computed at the aggregate of cash received by the Company, excluding amounts paid or
payable for accrued interest or accrued dividends;

 

(2) 
insofar as it consists of property other than cash, be computed at the fair market value thereof at the time of such issue,
as determined in good faith by the Board of Directors; and

 

(3) 
in the event Additional Shares of Common Stock are issued together with other shares or securities or other assets of the
Company for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses
(1) and (2) above, as determined in good faith by the Board of Directors.

 

 

 

 

    	 	4	 

     

    

 

(B) Options,
Rights and Convertible Securities. The consideration per share received by the Company for Additional Shares of Common Stock deemed
to have been issued pursuant to Subsection 5(d)(iii), relating to Options, Rights and Convertible Securities, shall be determined
by dividing

 

(1) 
the total amount, if any, received or receivable by the Company as consideration for the issue of such Options, Rights
or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating
thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company
upon the exercise of such Options, Rights or the conversion or exchange of such Convertible Securities, by

 

(2) 
the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision
contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or
exchange of such Convertible Securities.

 

(g)     Adjustment
for Stock Splits and Combinations. If the Company shall at any time or from time to time after the Original Issue Date effect
a subdivision of the outstanding Common Stock, the Conversion Price then in effect immediately before that subdivision shall be
proportionately decreased. If the Company shall at any time or from time to time after the Original Issue Date combine the outstanding
shares of Common Stock, the Conversion Price then in effect immediately before the combination shall be proportionately increased.
Any adjustment under this paragraph shall become effective at the close of business on the date the subdivision or combination
becomes effective.

 

(h)     Adjustment
for Certain Dividends and Distributions. In the event the Company at any time, or from time to time after the Original Issue
Date shall make or issue, a dividend or other distribution payable in Additional Shares of Common Stock, then and in each such
event the Conversion Price shall be decreased as of the time of such issuance, by multiplying the Conversion Price by a fraction:

 

(i) the
numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of
such issuance, and

 

(ii) the
denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time
of such issuance plus the number of shares of Common Stock issuable in payment of such dividend or distribution.

 

(i)     Adjustments
for Other Dividends and Distributions. In the event the Company at any time or from time to time after the Original Issue
Date shall make or issue a dividend or other distribution payable in securities of the Company other than shares of Common Stock,
then and in each such event provision shall be made so that the holders of the Notes shall receive upon conversion thereof in
addition to the number of shares of Common Stock receivable thereupon, the amount of securities of the Company that they would
have received had their Notes been converted into Common Stock on the date of such event and had thereafter, during the period
from the date of such event to and including the conversion date, retained such securities receivable by them as aforesaid during
such period given application to all adjustments called for during such period, under this paragraph with respect to the rights
of the holders of the Notes.

 

 

 

 

    	 	5	 

     

    

 

(j)     Adjustment
for Reclassification, Exchange, or Substitution. If the Common Stock issuable upon the conversion of the Notes shall be changed
into the same or a different number of shares of any class or classes of stock, whether by capital reorganization, reclassification,
or otherwise (other than a subdivision or combination of shares or stock dividend provided for above, or a reorganization, merger,
consolidation, or sale of assets for below), then and in each such event the holder of each Notes shall have the right thereafter
to convert such share into the kind and amount of shares of stock and other securities and property receivable upon such reorganization,
reclassification, or other change, by holders of the number of shares of Common Stock into which such Notes might have been converted
immediately prior to such reorganization, reclassification, or change, all subject to further adjustment as provided herein.

 

6. 
Warrant to Purchase Additional Stock. The note holder shall be given a warrant equal to 10% of the shares
purchased, to purchase common restricted stock of the Company that is subject to a twelve (12) month holding period, or regulation
144 holding period, and shall retain the trickle out restrictions contained in this agreement. The price of the warrant will be
One Dollar and Fifty cents ($1.50) and the term of the warrant shall be for one year from the investment date. The amount of warrants
shall the principle amount of this note divided by the conversion price of this note.

 

No
Rights as Stockholder. This Note does not entitle Holder to voting rights or any other right as a shareholder of the Company
before the conversion hereof.

 

7. 
Loss, Theft or Destruction of Note. Upon receipt by the Company of evidence reasonably satisfactory to the
Company of the loss, theft or destruction of this Note and of indemnity or security reasonably satisfactory to the Company, the
Company shall make and deliver a new Note that shall carry the same rights to interest (unpaid and to accrue) carried by this
Note, stating that such Note is issued in replacement of this Note, making reference to the original date of issuance of this
Note (and any successor hereto) and dated as of such cancellation, in lieu of this Note.

 

8.
Severability. Every provision of this Note is intended to be severable. If any term or provision hereof is declared
by a court of competent jurisdiction to be illegal or invalid for any reason whatsoever, such illegality or invalidity shall not
affect the balance of the terms and provisions hereof, which terms and provisions shall remain binding and enforceable.

 

9.
Miscellaneous.

 

(a)     No
Fractional Units or Scrip. No fractional shares or scrip representing fractional Units shall be issued upon the conversion
of this Note. In lieu of any fractional shares to which Holder otherwise would be entitled, the Company shall make a cash payment
equal to the Conversion Price multiplied by such fraction.

 

 

 

 

    	 	6	 

     

    

 

(b)     Issue
Date. The provisions of this Note shall be construed and shall be given effect in all respects as if this Note had been issued
and delivered by the Company on the earlier of the date hereof or the date of issuance of any Note for which this Note is issued
in replacement. This Note shall be binding on any successor or assign of the Company.

 

(c)     Governing
Law. This Note shall constitute a contract under the laws of the State of Delaware and for all purposes shall be construed
in accordance with and governed by the laws of the State of Delaware, without regard to the conflicts of law provisions thereof.

 

(d)     Compliance
with Usury Laws. The Company and Holder intend to comply with all applicable usury laws. In fulfilling this intention, all
agreements between the Company and Holder are expressly limited so that the amount of interest paid or agreed to be paid to Holder
for the use, forbearance, or detention of money under this Note shall not exceed the maximum amount permissible under applicable
law.

 

If
for any reason payment of any amount required under this Note shall be prohibited by law, then the obligation shall be reduced
to the maximum allowable by law. If for any reason Holder receives as interest an amount that would exceed the highest lawful
rate, then the amount which would constitute excessive interest shall be applied to the reduction of the principal of this Note
and not to the payment of interest. If any conflict arises between this provision and any provision of any other agreement between
the Company and Holder, then this provision shall control.

 

(e)     Legal
Representation. Holder agrees and represents that such party has been represented by such party's own legal counsel with regard
to all aspects of this Note, or if such party is acting without legal counsel, that such party has had adequate opportunity and
has been encouraged to seek the advice of such party's own legal counsel prior to the execution of this Agreement.

 

(f)     Jurisdiction.
Any action whatsoever brought upon or relating to this Note shall be instituted and prosecuted in the state courts located in
Orange County, California, or the federal district court therefore, and each party waives the right to change the venue. The parties
hereto further consent to accept service of process in any such action or proceeding by certified mail, return receipt requested,

 

(g)     Restrictions.
Holder acknowledges that all shares of common stock acquired upon the conversion of this Note shall be subject to restrictions
on resale imposed by state and federal securities laws.

 

(h)     Assignment.
Subject to restrictions on resale imposed by state and federal securities laws, Holder may assign this Note or any of the rights,
interests or obligations hereunder, by operation of law or otherwise, in whole or in part, to any person or entity so long as
such assignee agrees to be bound by the terms and conditions of the Agreement (including the representations and warranties of
the purchasers therein). Effective upon any such assignment, the person or entity to whom such rights, interests and obligations
are assigned shall have and exercise all of Holder’s rights, interests and obligations hereunder as if such person or entity
were the original Holder of this Note.

 

 

 

 

    	 	7	 

     

    

 

(i)     Notices.
Any notice, request or other communication required or permitted hereunder shall be given upon personal delivery, overnight courier
or upon the fifth (5th) day following mailing by registered mail (or certified first class mail if both the addresser and addressee
are located in the United States), postage prepaid and addressed to the parties hereto as follows:

 

	 	To the Company:	Odyssey Group International , Inc.
	 	 	2372 Morse Ave
	 	 	Irvine CA 92614
	 	 	Attention: Investor Relations
	 	 	 
	 	To Holder:	At the address set forth on the signature page hereto or to such other single place as any
    single addressee designates by written notice to the other addressee.

 

 

 

 

[SIGNATURE PAGE TO FOLLOW]

 

 

 

 

 

 

 

 

 

 

 

    	 	8	 

     

    

IN WITNESS WHEREOF, Odyssey Group
International, Inc. has caused this Secured Convertible Promissory Note to be executed by its officer thereunto duly authorized.

 

 

	 	The “Company”:
	 	 
	 	ODYSSEY GROUP INTERNATIONAL , INC.,
	 	a Nevada corporation
	 	 
	Accepted and Agreed to:	/s/ Joseph Michael Redmond
	 	Chief Executive Officer
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	DATE 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	The “Holder”:
	 	Print Name
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	Signature:	 
	 	 	 	 
	 	Date:	 	 
	 	 	 	 
	 	Address:	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	Phone: 	 	 
	 	 	 	 
	 	Email:	 	 
	 	The Company communicates press releases, updates
    and Investor Relations correspondence by email. Some information may be personal and/or tax information to the investor and
    may be considered sensitive in nature. By providing your email, you agree to allow the Company, Odyssey Group International,
    Inc. to contact you in this manner.

 

 

 

 

 

    	 	9	 

     

    

 

 

 

NOTICE OF CONVERSION TO STOCK

 

TO BE SENT IN AT TIME OF CONVERSION
ONLY

 

Odyssey Group International, Inc.

2372 Morse Ave

Irvine CA 92614

 

This Notice is provided
to inform you that the undersigned irrevocably elects to convert the Convertible Promissory Note (the “Note”) of Odyssey
Group International, Inc., a Nevada corporation (the “Company”), as provided in Section 5 of the Note, effective as
of the date written below.

 

The conversion price
of the Note shall be determined in accordance with Section 5. The number of shares to which the undersigned will be entitled shall
be determined by dividing (i) the principal of and accrued interest on this Note set forth below by (ii) the conversion price.

 

Effective as of the
Conversion Date this Note is cancelled and terminated as to the amount of the principal and interest set forth below. The undersigned
will receive a stock certificate of Odyssey Group International, Inc. representing the number of shares of stock into which the
Company Common Stock is converted.

 

	Date:_____________, 20_____	_____________________
	(Year after funds cleared)	Signature
	 	 
	 	_____________
	 	Print Name
	 	 
	Principal amount: $ _____	Address:
	 	____________________
	Accrued interest: $_____	____________________
	Number of Shares: ______	____________________

 

 

 

 

    	 	10	 

     

    

 

SUBSCRIPTION
AGREEMENT

Odyssey Group
International, Inc.

 

	1.	Investment
	 	 
	 	The undersigned (“Buyer”) subscribes for $ ______________
of a Promissory Note that may convert to common stock at $1.00 per share of Odyssey Group International, Inc., or at a 10%
discount to the market price on the date of conversion which ever is lower, however, in no instance shall the conversion price
be lower than eighty cents ($0.80) per share.

	 	 
	 	PLEASE MAKE CHECKS PAYABLE TO: Odyssey Group International, Inc. or wire funds to the following bank
               account:
	 	 
	 	Odyssey Group International, Inc.
	 	5/3 Bank
	 	33 W. Huron St
	 	Chicago, IL 60654
	 	Account #
	 	Routing #

 

 

	2.	Investor Information.	 	 	 	 	 
	 	Name (type or print)	 	 	 	 	 
	 	SSN/EIN/Taxpayer I.D.	 	 	 	 	 
	 	E-mail address: 	 	 	 	 	 	 	 
	 	Address:	 	 	 	 	 	 	 	 
	 	Business Phone:	(  )	 	 	 	Home Phone:	(  )	 
	 	 	 	 	 	 	 	 	 
	 	Joint Name (type or print if applicable)	 	SSN/EIN/Taxpayer I.D.
	 	 	 	 
	 	E-mail address: 	 	 	 	 	 	 	 
	 	Address:	 	 	 	 	 	 	 	 
	 	Business Phone:	(  )	 	 	 	Home Phone:	(  )	 
	 	 	 	 	 	 	 	 	 

 

	3.	Type of Ownership. (You must check one box)	 	 
	 	☐  Individual	☐  Custodian for ________________________	 	 
	 	☐  Tenants in Common	☐  Uniform Gifts to Minors Act of the State of: ______________	 

 

 

 

 

 

 

 

    	 	11	 

     

    

 

	 	☐ 	Corporation (Inc., LLC, LP) Please List all officers, directors, partners, managers, etc.:
	 	☐ 	Joint Tenants with rights of Survivorship
	 	☐ 	Partnership (Limited Partnerships use “Corporation”)
	 	☐ 	Trust
	 	☐ 	Community Property
	 	☐ 	Other (please explain) ______________________________________________________________
	 	 	 
	 	THE PURCHASE OF THE CONVERTIBLE PROMISSORY NOTE OF THE ODYSSEY GROUP INTERNATIONAL,
    INC. INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE
    INVESTMENT. I CERTIFY THAT I AM AN ACCREDITED INVESTOR AND HAVE COMPLETED THE INVESTOR QUESTIONAIRE ATTACHED HERETO AS EXHIBIT
    2.

 

 

	4.	Further Representations, Warrants and Covenants. Buyer hereby represents, warrants,
                  covenants and agrees as follows:
	 	 
		(a)	Buyer
                                         is at least eighteen (18) years of age with an address as set forth in this Subscription
                                         Agreement.

 

		(b)	Except as set forth in the
                                         Offering Memorandum and the exhibits thereto, no representations or warranties, oral
                                         or otherwise, have been made to Buyer by the Company or any other person, whether or
                                         not associated with the Company or this offering. In entering into this transaction,
                                         Buyer is not relying upon any information, other than that contained in the Offering
                                         Memorandum and the exhibits thereto and the results of any independent investigation
                                         conducted by Buyer at Buyer’s sole discretion and judgment.

 

		(c)	Buyer understands that his
                                         or her investment in the Convertible Debenture is speculative and involves a high degree
                                         of risk, and is not recommended for any person who cannot afford a total loss of their
                                         investment. Buyer is able to bear the economic risks of an investment in the Offering
                                         and at the present time can afford a complete loss of such investment. Buyer has read
                                         the Risk section of the Annual Report and 10K that Odyssey Group international submitted
                                         to the SEC on November 2, 2019 and is also attached here as Exhibit 1.

 

		(d)	Buyer is under no legal disability
                                         nor is Buyer subject to any order, which would prevent or interfere with Buyer’s
                                         execution, delivery and performance of this Subscription Agreement or his or her purchase
                                         of the Convertible Debenture. The Convertible Debenture]s being purchased solely for
                                         Buyer’s own account and not for the account of others and for investment purposes
                                         only, and are not being purchased with a view to or for the transfer, assignment, resale
                                         or distribution thereof, in whole or part. Buyer has no present plans to enter into any
                                         contract, undertaking, agreement or arrangement with respect to the transfer, assignment,
                                         resale or distribution of any of the Convertible Debenture.

 

 

 

 

 

    	 	12	 

     

    

 

		(e)	Buyer has (i) adequate means
                                         of providing for his or her current financial needs and possible personal contingencies,
                                         and has no present need for liquidity of the investment in the Convertible Debenture,
                                         and (ii) a liquid net worth (that is, net worth exclusive of a primary residence, the
                                         furniture and furnishings thereof, and automobiles) which is sufficient to enable Buyer
                                         to hold the Convertible Debenture indefinitely.

 

		(f)	If the Buyer is acting without
                                         a Purchaser Representative, Buyer has such knowledge and experience in financial and
                                         business matters that Buyer is fully capable of evaluating the risks and merits of an
                                         investment in the Offering.

 

		(g)	Buyer has been furnished
                                         with the Offering Memorandum. Buyer understands that Buyer shall be required to bear
                                         all personal expenses incurred in connection with his or her purchase of the Convertible
                                         Debenture, including without limitation, any fees which may be payable to any accountants,
                                         attorneys or any other persons consulted by Buyer in connection with his or her investment
                                         in the Offering.

 

		(h)	I certify that I had individual
                                         income over $200,000 (or joint income with my spouse of more than $300,000) in each of
                                         the past two years and reasonably expect to reach the same level in the current year,
                                         AND/OR I have an individual net worth in excess of $1,000,000.

 

5.             
 Indemnification

 

Buyer
acknowledges an understanding of the meaning of the legal consequences of Buyer’s representations and warranties contained
in this Subscription Agreement and the effect of his or her signature and execution of this Agreement, and Buyer hereby agrees
to indemnify and hold the Company and each of its officers and/or directors, representatives, agents or employees, harmless from
and against any and all losses, damages, expenses or liabilities due to, or arising out of, a breach of any representation, warranty
or agreement of or by Buyer contained in this Subscription Agreement.

 

6.             
 Acceptance of Subscription

 

It
is understood that this subscription is not binding upon the Company until accepted by the Company, and that the Company has the
right to accept or reject this subscription, in whole or in part, in its sole and complete discretion. If this subscription is
rejected in whole, the Company shall return to Buyer, without interest, the Payment tendered by Buyer, in which case the Company
and Buyer shall have no further obligation to each other hereunder. In the event of a partial rejection of this subscription,
Buyer’s Payment will be returned to Buyer without interest, whereupon Buyer agrees to deliver a new payment in the amount
of the purchase price for the amount of the common stock to be purchased hereunder following a partial rejection of this subscription.

 

7.             
 Governing Law

 

This
Subscription Agreement shall be governed and construed in all respects in accordance with the laws of the State of California
without giving effect to any conflict of laws or choice of law rules.

 

 

 

[SIGNATURE
PAGE TO FOLLOW]

 

 

 

    	 	13	 

     

    

 

 

IN WITNESS WHEREOF,
this Subscription Agreement has been executed and delivered by the Buyer and by the Company on the respective dates set forth
below.

 

 

 

Signature
of Buyer

 

 

By:
__________________________________________

PRINT
Account Holder's Name

 

Signature:
_____________________________________

 

Date: _________________________________________

  

 

 

 

Investor’s
Subscription Agreement accepted:

 

Accepted
By: /s/ J. Michael Redmond                                                                  

Odyssey Group International, Inc.

 

 

Date: _____________________________________

 

 

Deliver
completed Subscription Agreements and checks to:

 

Odyssey
Group International, Inc.

2372
Morse Avenue

Irvine,
CA 92614

 

 

 

 

 

 

 

    	 	14	 

     

    

 

Exhibit 1 - Risk
Factors

Risks Relating
to Our Business

 

In addition to the
risks set forth below, certain risk are set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended
July 31, 2018, filed with the SEC on November 2, 2019. Such Annual Report is available at www. sec.gov.

 

Our success depends
on the viability of our business model, which is unproven and may be unfeasible.

 

Our revenue and
income potential are unproven, and the business model of Odyssey Group is new. Our new business model is based on a variety of
assumptions based on a growing trend in the Health Care Systems in the United States and many other countries, where we are seeing
a movement towards preventative medicine that is directly decreasing general health care costs. The CardioMap, through its screening
and predictive values, is a tool that might be implemented in this preventative approach. Considering heart disease-caused deaths
are still the number one cause of death and one of the most important health care costs factors, the CardioMap device has potential
value in any doctor’s practice. Once approved, it could be an ideal device allowing insurance companies to cut costs through
early diagnostic and preventative care. These assumptions may not reflect the business and market conditions we actually face.
As a result, our operating results could differ materially from those projected under our business model, and our business model
may prove to be unprofitable.

 

Our
limited operating history creates substantial uncertainty about future results.

 

We have limited
operating history and operations on which to base expectations regarding our future results and performance. In order to succeed,
we must do most, if not all, of the following:

 

		·	raise
                                         equity to support our operating costs and to have sufficient funds to develop,
                                         market and sell our products;

 

		·	continue
                                         to identify and establish relationships with customers, distributors and vendors;

 

		·	attract,
                                         integrate, retain and motivate qualified management and sales personnel;

 

		·	successfully
                                         execute our business strategies;

 

		·	respond
                                         appropriately and timely to competitive developments; and

 

		·	develop,
                                         enhance, promote and carefully manage our corporate identity.

 

Our business will
suffer if we are unable to accomplish these and other important business objectives. We are uncertain as to when, or whether,
we will fully implement our contemplated business plan and strategy or become profitable.

 

 

 

 

    	 	15	 

     

    

 

Failure to implement
our business strategy could adversely affect our operations.

 

Our financial position,
liquidity and results of operations depend on our management’s ability to execute our business strategy. Key factors involved
in the execution of the business strategy include:

 

		Ø	achieving
                                         the desired cost of goods on inventory;

 

		Ø	successful
                                         sales through indirect sales distribution;

 

		Ø	Obtaining
                                         the required regulatory clearances from the FDA;

 

		Ø	continued
                                         investment in technology to support operating efficiency; and

 

		Ø	continued
                                         access to significant funding and liquidity sources.

 

Our failure or inability
to execute any element of our business strategy could materially adversely affect our financial position, liquidity and results
of operations.

 

Our inability
to attract, train and retain additional qualified personnel may harm our business and impede the implementation of our business
strategy.

 

We need to attract,
integrate, motivate and retain a significant number of additional personnel in 2019 and beyond. Competition for these individuals
in our industry and geographic region is intense, and we may be unable to attract, assimilate or retain such highly qualified
personnel in the future. Our business cannot continue to grow if we are unable to attract such qualified personnel. Our failure
to attract and retain highly trained personnel that are essential to our business may limit our growth rate, which would harm
our business and impede the implementation of our business strategy as contemplated in this Memorandum.

 

Our
failure to defend the Company from infringement litigation.

 

The Company could
be subject to potential infringement actions. The Company's business is "Patent intensive", requiring the Company to
constantly search for patented technologies that are not already used by competitors. Any claims for infringement, with or without
merit and whether based on allegations that its technology or its intellectual property claims infringe upon the rights of others,
could subject the Company to costly litigation and the diversion of financial and human resources, regardless of the ultimate
resolution of the claim. If these claims are successful, the Company may be required to modify its products or services, and pay
financial damages or to attempt to negotiate with third parties for licensing.

 

Our
inability to maintain sufficient product liability insurance.

 

The Company may
incur product liability for products sold through its distribution chain. Consumers may sue if products sold through its distribution
chain or are purchased through the Company-operated websites are defective or injure the user. This type of claim could require
the Company to spend significant time and money in litigation or to pay significant damages. At this time the Company carries
no product liability insurance. As a result, any legal claims, whether or not successful, could seriously damage its reputation
and business.

 

 

 

 

    	 	16	 

     

    

 

Our
products are subject to substantial federal and state regulations.

 

The Company's research
and development activities and the manufacturing and marketing of the Company's products are subject to the laws, regulations,
and guidelines and, in some cases, regulatory approvals of governmental authorities in the United States and other countries in
which the products are or will be marketed. Specifically, in the United States, the Food and Drug Administration ("FDA")
regulates, among other areas, new medical device approvals, over the counter drugs and clinical trials of new products and services
to establish the proper labeling, safety and efficacy of these products and services and the accuracy of certain marketing claims.

 

Risks Relating
to This Offering

 

Our
management has broad discretion regarding how to use the proceeds from the Offering.

 

We intend to use
the proceeds from the Offering for general corporate purposes, including working capital, capital expenditures, product enhancements,
regulatory filings to the FDA and to begin initial marketing efforts. In any case, we will have broad discretion over how we use
these proceeds. You will not have the opportunity to evaluate the economic, financial or other information on which we base our
decisions regarding how to use the proceeds from the Offering, and we may spend these proceeds in ways with which you disagree.
See “Use of Proceeds.”

 

You
may experience dilution in the value of the shares of common stock.

 

We anticipate offering
common stock or preferred stock in subsequent offerings which could cause further dilution.

 

Your
ownership will be diluted by future issuances of capital stock.

 

Our business strategy
requires us to raise additional equity capital through the sale of common stock or preferred stock. Your percentage of ownership
will become diluted as we issue new shares of stock. Stockholders have no rights to buy additional shares of stock in the event
we issue new shares of stock, known as preemptive rights. We may issue common stock, convertible debt or common stock pursuant
to a public offering or a private placement, upon exercise of warrants or options, or to sellers of properties we directly or
indirectly acquire instead of, or in addition to, cash consideration. Investors purchasing common stock in the Offering who do
not participate in any future stock issues will experience dilution in the percentage of the issued and outstanding stock they
own.

 

Our
common stock is deemed to be a “penny stock,” which may make it more difficult for investors to sell their shares
due to suitability requirements.

 

Our common stock
is deemed to be a "penny stock" as that term is defined in Rule 3a51-1 promulgated under the 1934 Act, as amended. This
classification reduces the potential market for our common stock by reducing the number of potential investors. This would be
detrimental to the development of active trading in our stock and make it more difficult for investors in our common stock to
sell shares to third parties or to otherwise dispose of them. This could also cause our stock price to decline or impede any increase
in price. Penny stocks are stocks:

 

		Ø	with
                                         a price of less than $5.00 per share;

 

		Ø	that
                                         are not traded on a "recognized" national exchange; or

 

		Ø	in
                                         issuers with net tangible assets less than $2 million (if the issuer has been in continuous
                                         operation for at least three years) or $10 million (if in continuous operation for less
                                         than three years), or with average revenues of less than $6 million for the last three
                                         years.

 

 

 

    	 	17	 

     

    

 

Broker-dealers dealing
in penny stocks are required to provide potential investors with a document disclosing the risks of penny stocks. Moreover, broker-dealers
are required to determine whether an investment in a penny stock is a suitable investment for a prospective investor. Many broker-dealers
will not offer penny stocks to their clients. Moreover, many investors are disinclined to purchase penny stocks.

 

A limited number
of stockholders collectively own a significant portion of our common shares and may act, or prevent corporate actions, to the
detriment of other stockholders.

 

A limited number
of stockholders, including our founders and members of the Board of Directors and our management, currently own a significant
portion of our outstanding common shares. Accordingly, these stockholders may, if they act together, exercise significant influence
over all matters requiring stockholder approval, including the election of a majority of our directors and the determination of
significant corporate actions. This concentration could also have the effect of delaying or preventing a change in control that
could otherwise be beneficial to our stockholders.

 

Our articles
of incorporation could be amended at any time by a small group of persons, who control over 50% of the our shares, to issue an
unlimited number of common and preferred shares, and significant issuances of common or preferred shares could dilute the share
ownership of our stockholders, deter or delay a takeover of us that our stockholders may consider beneficial or depress the trading
price of our common shares.

 

Our articles of
incorporation do not currently permit us to issue an unlimited number of common and preferred shares, but a small number of stockholders,
who own large blocks of shares, could amend the articles to allow for an issuance of a greater number of common shares and authorize
the issuance of preferred shares. If we were to issue a significant number of common shares, it would reduce the relative voting
power of previously outstanding shares. Such future issuances could be at prices less than certain stockholders paid for their
common shares. If we were to issue a significant number of common or preferred shares, these issuances could also deter or delay
an attempted acquisition of us that a stockholder may consider beneficial, particularly in the event that we issue preferred shares
with special voting or dividend rights. While certain national securities exchanges require a company to obtain stockholder approval
for significant issuances, we are not subject to those requirements. Significant issuances of our common or preferred shares,
or the perception that such issuances may occur, could cause the trading price of our common shares to drop.

 

 

 

 

 

 

    	 	18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00306-of-00352.parquet"}]]